CCL5 secreted by CD133+ ovarian carcinoma stem-like cells increases the invasive and metastatic properties of non-ovarian carcinoma stem-like cells (CD133–) and induces an EMT-like process [140]. The gene discussed is CCL5; the disease is ovarian carcinoma.